This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Natco Pharma Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Sathaiah Kandula: Innovator in Pharmaceutical Intermediates
Introduction
Sathaiah Kandula is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel intermediates for drug preparation. His work is characterized by a focus on commercially viable processes that can be scaled for industrial applications.
Latest Patents
Sathaiah Kandula holds a patent for "Intermediates for the preparation of eribulin thereof." This invention relates to novel intermediates of Eribulin and outlines a process for their preparation. The process is designed to be commercially viable and easily adoptable for plant-scale operations. The invention specifically addresses tetrahydrofuran compounds of formula I, X, XI, D, and B.
Career Highlights
Kandula is associated with Natco Pharma Limited, a prominent player in the pharmaceutical industry. His role at the company has allowed him to contribute to innovative drug development and enhance the company's portfolio of pharmaceutical products.
Collaborations
Throughout his career, Sathaiah Kandula has collaborated with talented professionals, including Bulli Babi Vipparla and Sreenivas Nagapuri. These collaborations have fostered a creative environment that encourages innovation and the advancement of pharmaceutical research.
Conclusion
Sathaiah Kandula's work in the field of pharmaceutical intermediates exemplifies the impact of innovation on drug development. His contributions not only advance scientific knowledge but also enhance the practical applications of pharmaceuticals in the industry.